Parexel International promotes Goldberg

Parexel International Corp., the Waltham pharmaceutical services company, said today that it promoted Mark A. Goldberg to chief operating officer.

Goldberg, who joined Parexel in 1997, most recently worked as the president of clinical research services and perceptive informatics.

"Dr. Goldberg has been an asset to Parexel's executive management team for more than 11 years," said Josef von Rickenbach, chairman and chief executive, in a statement. "His appointment as chief operating officer is in recognition of his strong leadership skills and increasing responsibilities, especially as we have expanded our clinical development capabilities and global footprint."

The company recently expanded into the Asia-Pacific region, he said. Parexel focuses on a contract research and development services, communications, and consulting services for the drug development industry.

Shares of Parexel rose 55 cents, or 2.1 percent, to $26.33 in morning trading on the Nasdaq Stock Market. (AP)